Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Study boost for atrial fibrillation drugs

March 17, 2010 Research and Development Pradaxa, VTE, Xarelto, apixaban, betrixaban

Two rival drugs have both shown benefits over warfarin in patients with atrial fibrillation, according to new research. Boehringer Ingelheim’s …
News

WuXi’s growth slows

March 17, 2010 Research and Development CRO, China, WuXi

WuXi Pharmatech, one of China’s leading contract research organisations, has been motoring ahead in recent quarters while its western counterparts …
News
William Burns

Bill Burns joins Shire board

March 17, 2010 Research and Development, Sales and Marketing Shire, appointment, research and development, sales and marketing

Former Roche pharma chief executive Bill Burns has joined the board at Shire as a non-executive director. Burns has also …
Appointment

Edinburgh BioQuarter appoints commercialisation director

March 16, 2010 Research and Development Edinburgh BioQuarter, appointment, research and development

Dr Michael Capaldi has joined Scottish life sciences research hub Edinburgh BioQuarter as director of commercialisation. He will lead a …
Appointment
GSKstephenne

GSK promotes Jean Stephenne to chairman, biologicals

March 15, 2010 Research and Development, Sales and Marketing GlaxoSmithKline, appointment, research and development, sales and marketing

GlaxoSmithKline has appointed Jean Stephenne chairman of GSK Biologicals, the company’s global vaccines division.He is currently president and general manager of …
Appointment

Contract research news in brief

March 15, 2010 Research and Development Bilcare, CRO, Kendle, Lonza, Medidata, Melbourn, Quintiles, RDNIB

Our round-up of developments in the contract research sector includes updates from Kendle, Bilcare, Quintiles, Melbourn Scientific, Lonza, and Medidata …
News

Pfizer suffers late-stage cancer drug failures

March 12, 2010 Research and Development Cancer, Pfizer, Sutent, figitumumab

Pfizer has suffered late-stage trial failures for Sutent and lung cancer candidate figitumumab. Kidney cancer drug Sutent (sunitinib) failed to …
News

GSK expands inflammatory alliance

March 12, 2010 Research and Development Cellzome, GlaxoSmithKline, rheumatoid arthritis

GlaxoSmithKline has formed a second strategic alliance with Cellzome to research new treatments for inflammatory diseases. GSK will buy into …
News

Novartis buys into Transgene’s lung cancer candidate

March 11, 2010 Research and Development Novartis, Transgene, immunotherapy, lung cancer

French biotech company Transgene has signed a deal with Novartis for the future development and marketing of its potential lung …
News

Investments boost Irish pharma sector

March 11, 2010 Research and Development, Sales and Marketing Ireland, PPD, Warner Chilcott

Contract research organisation PPD has officially opened its new research laboratory in Athlone, Ireland, and started recruiting for the first …
News

Five-year cardiovascular study planned for Onglyza

March 10, 2010 Research and Development, Sales and Marketing DPP-4, Onglyza, diabetes

Bristol-Myers Squibb and AstraZeneca are to embark on a five-year study of Onglyza in type II diabetes patients who may …
News

Abbott boosts pipeline with biotech acquisition

March 10, 2010 Research and Development, Sales and Marketing Abbott, Facet Biotech, daclizumab, volociximab

Abbott is to acquire US company Facet Biotech in a $450 million deal that will boost its oncology and immunology …
News
Worker protest

GSK Italy workers protest site closure

March 10, 2010 Research and Development GlaxoSmithKline, Italy, job cuts

Workers at a GlaxoSmithKline R&D facility in Verona, Italy, have taken to the streets to protest a decision to close …
News

Recentin disappoints in colorectal cancer

March 9, 2010 Research and Development AZ, Cancer, Recentin, colorectal cancer

AstraZeneca’s developmental oncology drug Recentin has failed to meet its primary endpoint in a phase II/III study. The once-daily oral …
News

Pfizer and King’s to collaborate on pain research

March 9, 2010 Research and Development King's, Pfizer, UK

Pfizer has partnered with King’s College London to create an open innovation laboratory for pain research.The project will include a …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026